Literature DB >> 14597486

Strain-specific immune response to Haemophilus influenzae in chronic obstructive pulmonary disease.

Sanjay Sethi1, Catherine Wrona, Brydon J B Grant, Timothy F Murphy.   

Abstract

Previous studies of immune response to Haemophilus influenzae after exacerbations of chronic obstructive pulmonary disease (COPD) have yielded contradictory results. Using homologous (infecting) strains and immunoassays to surface-exposed epitopes, we tested the hypothesis that adults with COPD make new antibodies to strain-specific, surface-exposed epitopes on H. influenzae after exacerbations. We collected clinical information, sputum, and serum monthly and during exacerbations from 81 patients with COPD over 56 months. Serum antibodies to H. influenzae after exacerbations associated with H. influenzae in sputum were detected with whole bacterial cell ELISA and bactericidal assays. An immune response to homologous H. influenzae occurred after 22 of 36 (61.1%) exacerbations with newly acquired strains compared with 7 of 33 (21.2%) exacerbations with preexisting strains (odds ratio [OR] = 4.4; 95%, 1.8 to 10.8; p = 0.001). An absence of an immune response was strongly associated with complement sensitivity (OR = 0.03; 95% confidence interval, 0.003 to 0.22; p = 0.001). New bactericidal antibodies developed after exacerbations were highly strain specific, showing bactericidal activity for only 11 of 90 (12.2%) heterologous strains. Development of an immune response to H. influenzae supports its role in causing exacerbations. The strain specificity of the immune response likely represents a mechanism of recurrent exacerbations.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14597486     DOI: 10.1164/rccm.200308-1181OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  48 in total

1.  Guidelines for the management of adult lower respiratory tract infections--full version.

Authors:  M Woodhead; F Blasi; S Ewig; J Garau; G Huchon; M Ieven; A Ortqvist; T Schaberg; A Torres; G van der Heijden; R Read; T J M Verheij
Journal:  Clin Microbiol Infect       Date:  2011-11       Impact factor: 8.067

Review 2.  COPD exacerbations.5: management.

Authors:  R Rodríguez-Roisin
Journal:  Thorax       Date:  2006-06       Impact factor: 9.139

3.  Modulation of airway inflammation by Haemophilus influenzae isolates associated with chronic obstructive pulmonary disease exacerbation.

Authors:  Dwight C Look; Cecilia L Chin; Lori J Manzel; Erin E Lehman; Alicia L Humlicek; Lei Shi; Timothy D Starner; Gerene M Denning; Timothy F Murphy; Sanjay Sethi
Journal:  Proc Am Thorac Soc       Date:  2006-08

Review 4.  COPD exacerbations . 2: aetiology.

Authors:  E Sapey; R A Stockley
Journal:  Thorax       Date:  2006-03       Impact factor: 9.139

Review 5.  Insights on persistent airway infection by non-typeable Haemophilus influenzae in chronic obstructive pulmonary disease.

Authors:  Christian P Ahearn; Mary C Gallo; Timothy F Murphy
Journal:  Pathog Dis       Date:  2017-06-01       Impact factor: 3.166

6.  Diversity of nontypeable Haemophilus influenzae strains colonizing Australian Aboriginal and non-Aboriginal children.

Authors:  J Pickering; H Smith-Vaughan; J Beissbarth; J M Bowman; S Wiertsema; T V Riley; A J Leach; P Richmond; D Lehmann; L-A Kirkham
Journal:  J Clin Microbiol       Date:  2014-02-05       Impact factor: 5.948

7.  Mucosal immunization of mice with recombinant OMP P2 induces antibodies that bind to surface epitopes of multiple strains of nontypeable Haemophilus influenzae.

Authors:  K L Ostberg; M W Russell; T F Murphy
Journal:  Mucosal Immunol       Date:  2008-10-29       Impact factor: 7.313

8.  Proteomic expression profiling of Haemophilus influenzae grown in pooled human sputum from adults with chronic obstructive pulmonary disease reveal antioxidant and stress responses.

Authors:  Jun Qu; Alan J Lesse; Aimee L Brauer; Jin Cao; Steven R Gill; Timothy F Murphy
Journal:  BMC Microbiol       Date:  2010-06-01       Impact factor: 3.605

9.  Safety and immunological outcomes following human inoculation with nontypeable Haemophilus influenzae.

Authors:  Patricia L Winokur; Kathryn Chaloner; Gary V Doern; Jennifer Ferreira; Michael A Apicella
Journal:  J Infect Dis       Date:  2013-05-28       Impact factor: 5.226

Review 10.  Newer fluoroquinolones in the treatment of acute exacerbations of COPD.

Authors:  Amit Patel; Robert Wilson
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2006
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.